SUBSCRIBE
SUBSCRIBE
News   Business

Abbott Laboratories Profit Jumps As All Business Units Shine

January 21, 2009 | 
1 min read
NEW YORK (Reuters) - Abbott Laboratories said on Wednesday fourth-quarter earnings jumped 28 percent on demand for its prescription drugs, nutritional products and medical devices, including its new Xience stent used to prop open coronary arteries.
Earnings
Abbott Laboratories
MORE ON THIS TOPIC
Weight loss pills available: A heap of GLP-1 pills
Manufacturing
Novo targets 10-fold jump in oral Wegovy manufacturing capacity by 2030
September 22, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Vector illustration of businessman as a superhero standing on top of a mountain, optimism, confidence in business concept
IPO
2026 IPO blitz continues with 4 new biotech filings
September 22, 2026
 · 
4 min read
 · 
Tristan Manalac
Business handshake trendy halftone art collage banner template. Partnership concept, successful agreement, closing a deal, securing a contract. Modern retro cut out vector illustration
Cancer
Boehringer Ingelheim bets up to $1B in AI-centered solid tumor collab with Envisagenics
September 22, 2026
 · 
2 min read
 · 
Tristan Manalac
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
BMS says goodbye to 265 New Jersey staff as reorg rolls on
September 22, 2026
 · 
95 min read
 · 
BioSpace Editorial Staff